These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 20107195)
41. The elevation of apoB in hypercholesterolemic patients is primarily attributed to the relative increase of apoB/Lp-PLA₂. Tellis CC; Moutzouri E; Elisaf M; Wolfert RL; Tselepis AD J Lipid Res; 2013 Dec; 54(12):3394-402. PubMed ID: 24092915 [TBL] [Abstract][Full Text] [Related]
42. Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment. Iwase M; Sonoki K; Sasaki N; Ohdo S; Higuchi S; Hattori H; Iida M Atherosclerosis; 2008 Feb; 196(2):931-6. PubMed ID: 17350631 [TBL] [Abstract][Full Text] [Related]
43. Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart Study. Schnabel R; Dupuis J; Larson MG; Lunetta KL; Robins SJ; Zhu Y; Rong J; Yin X; Stirnadel HA; Nelson JJ; Wilson PW; Keaney JF; Vasan RS; Benjamin EJ Atherosclerosis; 2009 Jun; 204(2):601-7. PubMed ID: 19135199 [TBL] [Abstract][Full Text] [Related]
44. The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia. Nakou ES; Filippatos TD; Georgoula M; Kiortsis DN; Tselepis AD; Mikhailidis DP; Elisaf MS Curr Med Res Opin; 2008 Jul; 24(7):1919-29. PubMed ID: 18513463 [TBL] [Abstract][Full Text] [Related]
45. Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease. Mourouzis K; Siasos G; Oikonomou E; Zaromitidou M; Tsigkou V; Antonopoulos A; Bletsa E; Stampouloglou P; Vlasis K; Vavuranakis M; Tousoulis D Lipids Health Dis; 2021 Feb; 20(1):12. PubMed ID: 33583415 [TBL] [Abstract][Full Text] [Related]
46. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker. Corson MA; Jones PH; Davidson MH Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871 [TBL] [Abstract][Full Text] [Related]
48. Relationship of lipoprotein-associated phospholipase A₂ mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial. Ridker PM; MacFadyen JG; Wolfert RL; Koenig W Clin Chem; 2012 May; 58(5):877-86. PubMed ID: 22419750 [TBL] [Abstract][Full Text] [Related]
49. Associations of PLA2G7 gene polymorphisms with plasma lipoprotein-associated phospholipase A2 activity and coronary heart disease in a Chinese Han population: the Beijing atherosclerosis study. Hou L; Chen S; Yu H; Lu X; Chen J; Wang L; Huang J; Fan Z; Gu D Hum Genet; 2009 Feb; 125(1):11-20. PubMed ID: 19034521 [TBL] [Abstract][Full Text] [Related]
50. Omega-3 fatty acids and lipoprotein associated phospholipase A(2) in healthy older adult males and females. Nelson TL; Hokanson JE; Hickey MS Eur J Nutr; 2011 Apr; 50(3):185-93. PubMed ID: 20706728 [TBL] [Abstract][Full Text] [Related]
51. Lp-PLA2 activity and mass are associated with increased incidence of ischemic stroke: a population-based cohort study from Malmö, Sweden. Persson M; Berglund G; Nelson JJ; Hedblad B Atherosclerosis; 2008 Sep; 200(1):191-8. PubMed ID: 18201705 [TBL] [Abstract][Full Text] [Related]
52. Energy Intake and Plasma Adiponectin as Potential Determinants of Lipoprotein-Associated Phospholipase A Ntzouvani A; Giannopoulou E; Fragopoulou E; Nomikos T; Antonopoulou S Lipids; 2019 Oct; 54(10):629-640. PubMed ID: 31489677 [TBL] [Abstract][Full Text] [Related]
53. Lipoprotein-associated phospholipase A₂ activity and mass in relation to vascular disease and nonvascular mortality. Heart Protection Study Collaborative Group J Intern Med; 2010 Oct; 268(4):348-58. PubMed ID: 21050287 [TBL] [Abstract][Full Text] [Related]
54. Lipoprotein-associated phospholipase A2, a novel cardiovascular inflammatory marker, in HIV-infected patients. Mangili A; Ahmad R; Wolfert RL; Kuvin J; Polak JF; Karas RH; Wanke CA Clin Infect Dis; 2014 Mar; 58(6):893-900. PubMed ID: 24336757 [TBL] [Abstract][Full Text] [Related]
55. Association of lipoprotein-associated phospholipase A(2) and endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA). Garg PK; McClelland RL; Jenny NS; Criqui M; Liu K; Polak JF; Jorgensen NW; Cushman M Vasc Med; 2011 Aug; 16(4):247-52. PubMed ID: 21708876 [TBL] [Abstract][Full Text] [Related]
57. Link between lipoprotein-associated phospholipase A2 gene expression of peripheral-blood mononuclear cells and prognostic outcome after acute ischemic stroke. Tsai TH; Chen YL; Lin HS; Liu CF; Chang HW; Lu CH; Chang WN; Chen SF; Wu CJ; Leu S; Ko SF; Yip HK J Atheroscler Thromb; 2012; 19(6):523-31. PubMed ID: 22447189 [TBL] [Abstract][Full Text] [Related]
58. Lipoprotein-Associated Phospholipase A2 and Incident Peripheral Arterial Disease in Older Adults: The Cardiovascular Health Study. Garg PK; Arnold AM; Hinckley Stukovsky KD; Koro C; Jenny NS; Mukamal KJ; Criqui MH; Furberg CD; Newman AB; Cushman M Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):750-6. PubMed ID: 26848158 [TBL] [Abstract][Full Text] [Related]
59. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease. Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J; Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330 [TBL] [Abstract][Full Text] [Related]
60. Plasma Lp-PLA(2) mass and apoB-lipoproteins that carry Lp-PLA(2) decrease after sodium. Constantinides A; Kerstens MN; Dikkeschei BD; van Pelt LJ; Tellis CC; Tselepis AD; Dullaart RP Eur J Clin Invest; 2012 Nov; 42(11):1235-43. PubMed ID: 22957745 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]